Skip to main content
SLSBio(Specialty Lab Solution Bio) Co., Ltd logo

SLSBio(Specialty Lab Solution Bio) Co., Ltd — Investor Relations & Filings

Ticker · 246250 ISIN · KR7246250005 KO Professional, scientific and technical activities
Open in API
Filings indexed 261 across all filing types
Latest filing 2023-03-14 AGM Information
Country KR South Korea
Listing KO 246250

About SLSBio(Specialty Lab Solution Bio) Co., Ltd

http://www.slabs.co.kr/

SLSBio (Specialty Lab Solution Bio) Co., Ltd. is a company specializing in laboratory solutions and support services for the pharmaceutical and biotechnology sectors. Its primary offerings include pharmaceutical quality control testing, clinical trial sample analysis, bioequivalence studies, drug stability testing, and new drug development support. In addition to its service portfolio, the company develops and manufactures diagnostic technologies, reagents, and other biological agents, supporting various stages of the drug development and commercialization lifecycle.

Recent filings

Filing Released Lang Actions
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집 결의) issued by SLS Bio. It details the date, location, and agenda items for the upcoming Annual General Meeting, including the approval of financial statements, election of directors and auditors, and remuneration limits. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the meeting and request their votes. Therefore, it falls under the Proxy Solicitation & Information Statement category.
2023-03-14 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for SLS Bio. It contains the agenda for the meeting, including reports on financial statements, director appointments, and remuneration limits. It also includes management's business overview and financial statements (balance sheet, income statement, etc.) as part of the 'Management Reference' (경영참고사항) required for shareholders to review before the meeting. This is a standard proxy solicitation document used to inform shareholders of an upcoming AGM and provide necessary materials for voting.
2023-03-14 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in South Korea. It details the change in share ownership by Timefolio Asset Management in SLs Bio. This type of filing is specifically used to notify the market when a shareholder's stake crosses certain thresholds (e.g., 5%), which corresponds to the 'Major Shareholding Notification' category.
2023-03-03 Korean
기타주요경영사항(내부결산실적등)(자율공시)
Earnings Release Classification · 100% confidence The document is a voluntary disclosure ('자율공시') of internal financial results ('내부결산실적') for the fiscal year 2022. It provides key financial highlights such as revenue, operating profit, and net income, comparing them to the previous year. Since this is an initial announcement of financial performance figures rather than a full annual report or a conference call transcript, it falls under the Earnings Release category. FY 2022
2023-02-10 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options). It details the issuance of stock options to employees, including the number of shares, exercise price, and legal basis (Articles of Incorporation). In the context of Korean financial regulatory filings (DART system), this is a standard disclosure regarding capital changes and equity-based compensation, which falls under the 'Regulatory Filings' (RNS) category as it is a specific corporate disclosure that does not fit into the other specialized categories like 'Director's Dealing' or 'Share Issue'.
2023-02-10 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and includes a '정정신고' (Correction Report) section. It details the issuance of stock options to employees, including the number of shares, exercise price, and legal basis (Articles of Incorporation). This type of filing relates to changes in capital structure and equity-based compensation, which falls under the 'Share Issue/Capital Change' category in the provided schema.
2023-02-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.